ic 261 has been researched along with 4-(3-cyclohexyl-5-(4-fluoro-phenyl)-3h-imidazol-4-yl)pyrimidin-2-ylamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Munoz, L | 1 |
| Baumann, U; Brunstein, E; García-Reyes, B; Gehring, T; Henne-Bruns, D; Jansen, B; Karasu, E; Knippschild, U; Leban, J; Peifer, C; Pichlo, C; Rathmer, B; Schade, D; Wesseler, F; Witt, L | 1 |
| Feng, S; Ji, P; Li, GB; Ma, S; Sun, QZ; Wang, ZR; Yan, HX; Yang, LL; Yang, SY; Zou, J | 1 |
1 review(s) available for ic 261 and 4-(3-cyclohexyl-5-(4-fluoro-phenyl)-3h-imidazol-4-yl)pyrimidin-2-ylamine
| Article | Year |
|---|---|
Non-kinase targets of protein kinase inhibitors.
Topics: Animals; Drug Design; Drug Evaluation, Preclinical; Humans; Molecular Targeted Therapy; Protein Kinase Inhibitors; Protein Kinases | 2017 |
2 other study(ies) available for ic 261 and 4-(3-cyclohexyl-5-(4-fluoro-phenyl)-3h-imidazol-4-yl)pyrimidin-2-ylamine
| Article | Year |
|---|---|
Discovery of Inhibitor of Wnt Production 2 (IWP-2) and Related Compounds As Selective ATP-Competitive Inhibitors of Casein Kinase 1 (CK1) δ/ε.
Topics: Adenosine Triphosphate; Benzimidazoles; Binding, Competitive; Casein Kinase 1 epsilon; Casein Kinase Idelta; Cell Line, Tumor; Cell Proliferation; Drug Design; Humans; Models, Molecular; Protein Conformation; Protein Kinase Inhibitors; Wnt Proteins | 2018 |
Discovery of N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamine derivatives as novel CK1 inhibitors using common-feature pharmacophore model based virtual screening and hit-to-lead optimization.
Topics: Casein Kinase I; Diamines; Dose-Response Relationship, Drug; Drug Discovery; High-Throughput Screening Assays; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Pyrimidines; Structure-Activity Relationship | 2012 |